Periprostatic fat measured on computed tomography as a marker for prostate cancer aggressiveness - Takeaways - MDSpire

Periprostatic fat measured on computed tomography as a marker for prostate cancer aggressiveness

  • By

  • Joep G. H. van Roermund

  • Gijsbert H. Bol

  • J. Alfred Witjes

  • J. L. H. Ruud Bosch

  • Lambertus A. Kiemeney

  • Marco van Vulpen

  • December 22, 2009

  • 0 min

Share

  • 1

    Obesity is linked to prostate cancer aggressiveness, with studies suggesting a correlation between fat distribution and disease severity.

  • 2

    Computed tomography (CT) provides a more accurate measurement of visceral fat compared to body mass index (BMI) for assessing prostate cancer risk.

  • 3

    The study analyzed 725 men with localized prostate cancer who underwent brachytherapy, focusing on periprostatic fat as a potential marker for aggressiveness.

  • 4

    Patients were stratified into fat-density groups, revealing significant associations between fat-density, BMI, and clinical characteristics.

  • 5

    The findings suggest that periprostatic fat density may serve as a better predictor of prostate cancer aggressiveness than BMI alone.

Original Source(s)

Related Content